Skip to main content

Assenagon Asset Management S.A.

Position in FATE — Fate Therapeutics Inc

CIK 1546007 SENNINGERBERG, N4

Position in FATE

as of Jun 30, 2026 · filed Jul 8, 2026
Position Value
$393,762
+$165,460 QoQ
Shares Held
145,838
-23.3% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 7 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. FATE ranks #61 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FATE

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $393,762 145,838
2026-03-31 $228,302 190,252
2025-12-31 $145,679 148,653
2025-09-30 $183,755 145,838
2025-06-30 $237,823 212,342
2025-03-31 $239,290 302,899
2024-12-31 $614,636 372,507
2024-09-30 $8,519,693 2,434,198
2024-06-30 $8,445,025 2,574,703
2024-03-31 $18,704,551 2,548,304
2023-12-31 $609,982 163,097
2023-09-30 $807,162 380,737
2023-06-30 $475,247 99,842
2022-09-30 $326,805 14,583
2022-06-30 $361,887 14,604
2022-03-31 $566,429 14,610
2021-12-31 $855,123 14,615
2021-09-30 $7,379,589 124,508
2021-06-30 $36,222,500 417,358
2020-12-31 $2,302,620 25,323
2020-09-30 $3,321,467 83,099
2020-06-30 $1,385,369 40,378